National Pension Service lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 570,291 shares of the company's stock after purchasing an additional 19,637 shares during the quarter. National Pension Service owned approximately 0.23% of HCA Healthcare worth $171,173,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Denali Advisors LLC boosted its position in shares of HCA Healthcare by 78.6% during the 4th quarter. Denali Advisors LLC now owns 2,500 shares of the company's stock valued at $750,000 after acquiring an additional 1,100 shares in the last quarter. Todd Asset Management LLC boosted its stake in HCA Healthcare by 1.7% during the 4th quarter. Todd Asset Management LLC now owns 136,917 shares of the company's stock worth $41,096,000 after acquiring an additional 2,348 shares during the last quarter. Keeler Thomas Management LLC bought a new position in HCA Healthcare in the fourth quarter valued at approximately $797,000. IFP Advisors Inc boosted its holdings in HCA Healthcare by 23.2% during the fourth quarter. IFP Advisors Inc now owns 9,444 shares of the company's stock worth $2,835,000 after purchasing an additional 1,777 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd raised its stake in shares of HCA Healthcare by 209.0% during the 4th quarter. Y Intercept Hong Kong Ltd now owns 18,587 shares of the company's stock worth $5,579,000 after purchasing an additional 12,571 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.
HCA Healthcare Trading Down 4.7 %
Shares of HCA stock traded down $15.16 on Friday, hitting $305.79. The company had a trading volume of 3,469,113 shares, compared to its average volume of 1,740,103. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The stock's 50-day moving average is $315.15 and its two-hundred day moving average is $349.39. The firm has a market cap of $75.94 billion, a P/E ratio of 13.92, a P/E/G ratio of 1.10 and a beta of 1.64.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the firm posted $5.90 earnings per share. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.94%. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare's payout ratio is presently 13.11%.
Analyst Ratings Changes
Several analysts recently weighed in on HCA shares. Truist Financial dropped their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a report on Monday, January 6th. Morgan Stanley dropped their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 17th. Royal Bank of Canada dropped their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. KeyCorp decreased their price target on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and an average target price of $385.67.
View Our Latest Report on HCA
Insider Buying and Selling at HCA Healthcare
In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company's stock.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report